FDA Adverse Event Injury Summary report: N

VALIANT CAPTIVIA

MDR report key: 3884930 · Received June 19, 2014

Report

Report Number
2953200-2014-01234
Event Type
Injury
Date Received
June 19, 2014
Date of Event
May 26, 2014
Report Date
May 26, 2014
Manufacturer
MEDTRONIC IRELAND
Product Code
MIH
PMA / PMN Number
P100040
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

A VALIANT CAPTIVIA STENT GRAFT SYSTEM WAS IMPLANTED IN THE PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 73MM FUSIFORM (ZONE 4) THORACIC ANEURYSM. VESSEL MORPHOLOGY WAS REPORTED AS THE PROXIMAL NECK DIAMETER OF SG SEAL ZONE IS 30.2X32.6MM AND DISTAL DIAMETER OF PROXIMAL NECK IS 30.8X33MM. PROXIMAL DIAMETER OF DISTAL NECK IS 40.7X44.3MM. DIAMETER PROXIMAL TO THE CELIAC ARTERY IS 40.8X40MM. PROXIMAL NECK LENGTH BY CENTERLINE IS 30MM. DURING THE INDEX PROCEDURE THE FIRST VALIANT STENT GRAFT WAS IMPLANTED AT THE PROXIMAL SIDE WITHOUT ISSUES. THEN THE SECOND VALIANT STENT GRAFT WAS IMPLANTED AND TOUCH-UP WAS CARRIED OUT WITH ANOTHER MANUFACTURER¿S BALLOON CATHETER. THE PHYSICIAN INFLATED THE BALLOON WITH IN IFU INSTRUCTIONS IN THE STENT GRAFT FABRIC. ANGIOGRAPHY CONFIRMED A DISSECTION ORIGINATING FROM THE GREATER CURVATURE SITE WHERE THE FIRST VALIANT STENT GRAFT WAS IMPLANTED. THE PHYSICIAN DECIDED TO TREAT THE DISSECTION BY ADDING ANOTHER MANUFACTURER¿S STENT GRAFT AND THE TYPE A DISSECTION WAS RESOLVED. NO LEAKS WERE IDENTIFIED AT THE END OF THE PROCEDURE. THE PHYSICIAN NOTED THE CAUSE OF THE DISSECTION DUE TO THE GREATER CURVATURE OF THE CALCIFIED SITE AND THE TIP OF THE BARE STENT CAUSED THE DISSECTION WHILE TOUCH UP WAS APPLIED DURING THE PROCEDURE. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS DOING FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
360115 VALIANT CAPTIVIA SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH MEDTRONIC IRELAND V01706774

Patients

Seq Age Sex Outcome Treatment
1 00090 YR Required Intervention